Skip to main navigation Skip to search Skip to main content

Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells

  • Scott Maxwell
  • , Jun Okabe
  • , Harikrishnan Kaipananickal
  • , Hanah Rodriguez
  • , Ishant Khurana
  • , Keith Al-Hasani
  • , Bryna S.M. Chow
  • , Eleni Pitsillou
  • , Tom C. Karagiannis
  • , Karin Jandeleit-Dahm
  • , Ronald C.W. Ma
  • , Yu Huang
  • , Juliana C.N. Chan
  • , Mark E. Cooper
  • , Assam El-Osta
  • Baker Heart and Diabetes Institute
  • Monash University, Australia
  • University of Melbourne
  • RMIT University
  • Heinrich Heine University Düsseldorf
  • Li Ka Shing Institute of Health Sciences
  • City University of Hong Kong

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Key PointsSet7 knockout improves diabetic glomerular structure and function and prevents diabetes-induced endothelial-mesenchymal transition (EDMT) by regulating Igfbp5.Set7 knockdown prevents, and (R)-PFI-2 hydrochloride reverses, diabetes-induced EDMT by regulating insulin growth factor binding protein 5.Set7 regulates the phenotypic EDMT switch, and inhibiting the methyltransferase attenuates glomerular injury in diabetic kidney disease.BackgroundHyperglycemia influences the development of glomerular endothelial cell damage, and nowhere is this more evident than in the progression of diabetic kidney disease (DKD). While the Set7 lysine methyltransferase is a known hyperglycemic sensor, its role in endothelial cell function in the context of DKD remains poorly understood.MethodsSingle-cell transcriptomics was used to investigate Set7 regulation in a mouse model of DKD, followed by validation of findings using pharmacological and short hairpin RNA inhibition inhibition of Set7.ResultsSet7 knockout (Set7KO) improved glomerular structure and albuminuria in a mouse model of diabetes. Analysis of single-cell RNA-sequencing data showed dynamic transcriptional changes in diabetic renal cells. Set7KO controls phenotype switching of glomerular endothelial cell populations by transcriptional regulation of the insulin growth factor binding protein 5 (IGFBP5). Chromatin immunoprecipitation assays confirmed that the expression of the IGFBP5 gene was associated with mono- and dimethylation of histone H3 lysine 4 (H3K4me1/2). This generalizability was investigated in human kidney and circulating hyperglycemic cells exposed to TGFβ1. We showed that the highly selective Set7 inhibitor (R)-PFI-2 hydrochloride attenuated indices associated with renal cell damage and mesenchymal transition, specifically (1) reactive oxygen species production, (2) IGFBP5 gene regulation, and (3) expression of mesenchymal markers. Furthermore, renal benefit observed in Set7KO diabetic mice closely corresponded in human glomerular endothelial cells with (R)-PFI-2 hydrochloride inhibition or Set7 short hairpin RNA silencing.ConclusionsSet7 regulates the phenotypic endothelial-mesenchymal transition switch and suggests that targeting the lysine methyltransferase could protect glomerular cell injury in DKD.PodcastThis article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_04_25_ASN0000000000000345.mp3.

Original languageEnglish
JournalJournal of the American Society of Nephrology
Volume35
Issue number6
Pages (from-to)733-748
Number of pages16
ISSN1046-6673
DOIs
Publication statusPublished - 1 Jun 2024

Keywords

  • diabetes
  • diabetes mellitus
  • diabetic kidney disease
  • diabetic nephropathy
  • endothelium
  • gene expression
  • gene transcription

Fingerprint

Dive into the research topics of 'Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells'. Together they form a unique fingerprint.

Cite this